Skip to Content

WATSON 461 (Glipizide 10 mg)

Pill with imprint WATSON 461 is White, Round and has been identified as Glipizide 10 mg. It is supplied by Watson Laboratories, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 461

Glipizide 10 mg WATSON 461
Glipizide 10 mg WATSON 461
Glipizide 10 mg WATSON 461  Front
Glipizide 10 mg WATSON 461  Back
Glipizide 10 mg WATSON 461
Glipizide 10 mg WATSON 461

Glipizide

Imprint:
WATSON 461
Strength:
10 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00591-0461 Watson Pharmaceuticals, Inc.
54569-3842 A-S Medication Solutions, LLC (repackager)
54868-3319 Physicians Total Care Inc. (repackager)
63874-0432 Altura Pharmaceuticals Inc. (repackager)
67544-0129 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide